title: Fahr's syndrome: literature review of current evidence.
abstract: Fahr's disease or Fahr's syndrome is a rare, neurological disorder characterized by abnormal calcified deposits in basal ganglia and cerebral cortex. Calcified deposits are made up of calcium carbonate and calcium phosphate, and are commonly located in the Basal Ganglia, Thalamus, Hippocampus, Cerebral cortex, Cerebellar Subcortical white matter and Dentate Nucleus. Molecular genetics of this disease haven't been studied extensively; hence evidence at the molecular and genetic level is limited. Fahr's disease commonly affects young to middle aged adults. Etiology of this syndrome does not identify a specific agent but associations with a number of conditions have been noted; most common of which are endocrine disorders, mitochondrial myopathies, dermatological abnormalities and infectious diseases. Clinical manifestations of this disease incorporate a wide variety of symptoms, ranging from neurological symptoms of extrapyramidal system to neuropsychiatric abnormalities of memory and concentration to movement disorders including Parkinsonism, chorea and tremors amongst others. Diagnostic criteria for this disease has been formulated after modifications from previous evidence and can be stated briefly, it consist of bilateral calcification of basal ganglia, progressive neurologic dysfunction, absence of biochemical abnormalities, absence of an infectious, traumatic or toxic cause and a significant family history. Imaging modalities for the diagnosis include CT, MRI, and plain radiography of skull. Other investigations include blood and urine testing for hematologic and biochemical indices. Disease is as yet incurable but management and treatment strategies mainly focus on symptomatic relief and eradication of causative factors; however certain evidence is present to suggest that early diagnosis and treatment can reverse the calcification process leading to complete recovery of mental functions. Families with a known history of Fahr's disease should be counseled prior to conception so that the birth of affected babies can be prevented. This review was written with the aim to remark on the current substantial evidence surrounding this disease.
authors.affiliation: Department of Medicine, Dow Medical College, DUHS, Karachi, Sindh, Pakistan. coolaslam8@hotmail.com.
authors.forename: Shafaq
authors.initials: S
authors.lastname: Saleem
authors.forename: Hafiz Muhammad
authors.initials: HM
authors.lastname: Aslam
authors.forename: Maheen
authors.initials: M
authors.lastname: Anwar
authors.forename: Shahzad
authors.initials: S
authors.lastname: Anwar
authors.forename: Maria
authors.initials: M
authors.lastname: Saleem
authors.forename: Anum
authors.initials: A
authors.lastname: Saleem
authors.forename: Muhammad Asim Khan
authors.initials: MA
authors.lastname: Rehmani
mesh_terms: D001480:Basal Ganglia Diseases / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000652:urine; D002114:Calcinosis / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male